Shift in disparities in hepatitis C treatment from interferon to DAA era: A population‐based cohort study
Janjua, N. Z., Islam, N., Wong, J., Yoshida, E. M., Ramji, A., Samji, H., Butt, Z. A., Chong, M., Cook, D., Alvarez, M., Darvishian, M., Tyndall, M., Krajden, M.
Published in Journal of viral hepatitis (01.08.2017)
Published in Journal of viral hepatitis (01.08.2017)
Get full text
Journal Article
MANAGEMENT OF URINARY INCONTINENCE IN HOSPITALIZED OLDER ADULTS WITH DEMENTIA – A SCOPING REVIEW
Ramji, A, Asaana, P, Rajabali, S, Hunter, K, Wagg, A
Published in Continence (Amsterdam) (01.09.2023)
Published in Continence (Amsterdam) (01.09.2023)
Get full text
Journal Article
Epidemiology, Treatment Patterns and Survival in Canadian Patients With Chronic Hepatitis B‐Related Hepatocellular Carcinoma
Sachar, Y., Congly, S. E., Burak, K. W., Manko, A., Ko, H. H., Ramji, A., Rahman, H. S., Talia, J., Jeyaparan, J., Wong, D. W., Fung, S., Cooper, C., Kelly, E. M., Ma, M. M., Bailey, R., Minuk, G., Wong, A., Doucette, K., Elkashab, M., Sebastiani, G., Wong, P., Coffin, C. S., Brahmania, M.
Published in Journal of viral hepatitis (01.11.2024)
Published in Journal of viral hepatitis (01.11.2024)
Get full text
Journal Article
Real-world utilization of the new fixed-dose combination elbasvir/grazoprevir in adult patients with chronic hepatitis C in Canada: Z-PROFILE study
Tam, E, Fraser, C, Tremblay, J, Conway, B, Trottier, B, Ramji, A, Borgia, S, Stewart, K, Trépanier, J, Chalabi, Y
Published in Journal of hepatology (2017)
Published in Journal of hepatology (2017)
Get full text
Journal Article
Are DAAs reducing barriers for HIV co-infected and people who inject drugs? A population based cohort study
Janjua, N, Islam, N, Wong, J, Yoshida, E.M, Ramji, A, Samji, H, Butt, Z.A, Chong, M, Cook, D, Alvarez, M, Tyndall, M, Krajden, M
Published in Journal of hepatology (2017)
Published in Journal of hepatology (2017)
Get full text
Journal Article
Grazoprevir plus peginterferon and ribavirin in treatment-naive patients with hepatitis C virus genotype 1 infection: a randomized trial
Lagging, M., Brown, A., Mantry, P. S., Ramji, A., Weilert, F., Vierling, J. M., Howe, A., Gendrano III, I. N., Hwang, P., Zhang, B., Wahl, J., Robertson, M., Mobashery, N.
Published in Journal of viral hepatitis (01.02.2016)
Published in Journal of viral hepatitis (01.02.2016)
Get full text
Journal Article
Efficacy and safety of ombitasvir/paritaprevir/ritonavir ± dasabuvir with ribavirin in adults with genotype 1 or genotype 4 chronic hepatitis C virus infection and child-pugh B decompensated cirrhosis
Mantry, P, Reddy, R, Cohen, E, Everson, G, Ramji, A, Zeuzem, S, Gordon, S, Yoshida, E, Sherman, M, Balart, L, Baumgarten, A, Lee, S, Fredrick, L.M, Abunimeh, M, Cohen, D.E, Shulman, N.S, Wilson, J
Published in Journal of hepatology (2017)
Published in Journal of hepatology (2017)
Get full text
Journal Article
Global real-world evidence of sofosbuvir/velpatasvir (SOF/VEL) as a highly effective treatment in underserved patient populations because of mental health disorders, incarceration or homelessness
Barrett, L., Rosati, S., Garcia-Retortillo, M., Wedemeyer, H., Teti, E., Hernández, FA Pérez, Selfridge, M., Wong, A., Rodriguez-Tajes, S., Morano-Amado, L.E., Brixko, C., Jimenez-Mutiloa, E., O'Loan, J., Milella, M., Campanale, F., Macedo, G., Guerra-Veloz, M., Maida, I., Ranieri, R., Martins, A., Bascia, A., Buti, M., Fernandez-Rodriguez, C.M., Conway, B., Foucher, J., Fagiuoli, S., Ramji, A., Fenech, M., Ryan, P., Borgia, S., Mangia, A., Mendez-Navarro, J., Ntalla, I., Hernández, C., Mertens, M., Vanstraelen, K., Calvaruso, V.
Published in Annals of hepatology (01.01.2022)
Published in Annals of hepatology (01.01.2022)
Get full text
Journal Article
Safety of Direct-Acting Antivirals-Based Therapy for the Treatment of Patients with Chronic Hepatitis C Virus Infection and Cirrhosis: Results from an International Multicenter Cohort Study
Maan, R, van Tilborg, M, Deterding, K, Ramji, A, van der Meer, A.J, Wong, F, Fung, S, Sherman, M, Manns, M.P, Cornberg, M, Wedemeyer, H, Janssen, H.L, de Knegt, R.J, Feld, J.J
Published in Journal of hepatology (2016)
Published in Journal of hepatology (2016)
Get full text
Journal Article
Ledipasvir/Sofosbuvir with Ribavirin for 12 Weeks is Effective and Safe in Treatment-Naïve Genotype-3 Hepatitis C-Infected Patients in Canada
Feld, J, Ramji, A, Shafran, S, Willems, B, Marotta, P, Huchet, E, Vachon, M.-L, Svarovskaia, E, Huang, K, Hyland, R, Yun, C, Brainard, D, McHutchison, J, Tam, E, Bailey, R, Cooper, C, Yoshida, E, Greenbloom, S, Elkhashab, M, Borgia, S, Swain, M
Published in Journal of hepatology (2016)
Published in Journal of hepatology (2016)
Get full text
Journal Article
O33 SVR AND SAFETY OF LOWER DOSES OF MK-5172 25 mg AND 50 mg DAILY FOR 12 WEEKS IN HCV GENOTYPE (G)1 TREATMENT-NAIVE NON-CIRRHOTIC PATIENTS
Lagging, M, Brown, A, Weiland, O.R, Mantry, P, Ramji, A, Weilert, F, Vierling, J.M, Talaty, J, Gendrano, I.N, Hwang, P, Zhang, B, Wahl, J, Robertson, M, Mobashery, N
Published in Journal of hepatology (01.04.2014)
Published in Journal of hepatology (01.04.2014)
Get full text
Journal Article
Randomised clinical trial: the efficacy of treatment, guided by a shorter duration of response, using peginterferon alfa-2a plus ribavirin for hepatitis C virus other than genotypes 2 or 3
Lee, S. S., Sherman, M., Ramji, A., Greenbloom, S., Elkashab, M., Pluta, H., Hilzenrat, N., Balshaw, R., Usaty, C., Myers, R. P.
Published in Alimentary pharmacology & therapeutics (01.01.2012)
Published in Alimentary pharmacology & therapeutics (01.01.2012)
Get full text
Journal Article
1205 SVR-12 AMONG G1/4 TREATMENT-NAIVE PATIENTS RECEIVING MERICITABINE IN COMBINATION WITH PEG-IFNa-2A/RBV: INTERIM ANALYSIS FROM THE JUMP-C STUDY
Pockros, P, Jensen, D, Tsai, N, Taylor, R, Ramji, A, Cooper, C, Dickson, R, Tice, A, Kulkarni, R, Najera, I, Vierling, J, Thommes, J
Published in Journal of hepatology (01.04.2012)
Published in Journal of hepatology (01.04.2012)
Get full text
Journal Article
1207 TRIPLE THERAPY WITH DACLATASVIR (DCV; BMS-790052), PEGINTERFERON ALFA-2A AND RIBAVIRIN IN HCV-INFECTED PRIOR NULL AND PARTIAL RESPONDERS: 12-WEEK RESULTS OF PHASE 2B COMMAND-2 TRIAL
Ratziu, V, Gadano, A, Pol, S, Hézode, C, Ramji, A, Cheng, W, Sulkowsk, M, Everson, G, Diva, U, McPhee, F, Wind-Rotolo, M, Hughes, E.A, Yin, P.D, Schnittman, S
Published in Journal of hepatology (01.04.2012)
Published in Journal of hepatology (01.04.2012)
Get full text
Journal Article
1418 DACLATASVIR COMBINED WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN FOR 12 OR 16 WEEKS IN PATIENTS WITH HCV GENOTYPE 2 OR 3 INFECTION: COMMAND GT2/3 STUDY
Dore, G.J, Lawitz, E, H'ezode, C, Shafran, S, Ramji, A, Tatum, H, Taliani, G, Tran, A, Brunetto, M, Zaltron, S, Strasser, S, Weis, N, Ghesquiere, W, Lee, S, Larrey, D, Pol, S, Harley, H, George, J, Fung, S, de L'edinghen, V, Hagens, P, Cohen, D, Cooney, E, Noviello, S, Hughes, E
Published in Journal of hepatology (01.04.2013)
Published in Journal of hepatology (01.04.2013)
Get full text
Journal Article
1359 FIRST SVR DATA WITH THE NUCLEOSIDE ANALOGUE POLYMERASE INHIBITOR MERICITABINE (RG7128) COMBINED WITH PEGINTERFERON/RIBAVIRIN IN TREATMENT-NAIVE HCV G1/4 PATIENTS: INTERIM ANALYSIS FROM THE JUMP-C TRIAL
Pockros, P, Jensen, D, Tsai, N, Taylor, R.M, Ramji, A, Cooper, C, Dickson, R, Tice, A, Stande, S, Ipe, D, Thommes, J.A, Vierling, J.M
Published in Journal of hepatology (01.03.2011)
Published in Journal of hepatology (01.03.2011)
Get full text
Journal Article